Femasys Inc (FEMY) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Femasys reported revenue of $2.3M, up 40.8% from $1.6M the year before. Net income was -$18.6M (a -812.3% net margin), or -$9.40 per diluted share. Gross margin was 62.0% and operating margin was -767.0%. Operating activities generated -$18.7M of cash, leaving -$19.2M of free cash flow. At fiscal year end, Femasys held $20.7M in total assets against $14.9M in total liabilities, including $9.3M of cash and equivalents.
Open the full interactive Femasys financials → Quarterly statements, key ratios, valuation history and price charts.
Femasys Key Stats
| Share Price | $1.76 |
|---|---|
| Market Cap | $5.9M |
| Revenue YoY Growth | +40.8% |
| 52-Week Range | $1.75 – $20.80 |
| Shares Outstanding | 3.4 million (basic, 2026 Q2) |
Femasys Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.2M | $1.2M | $1.1M | $1.6M | $2.3M |
| Cost of Goods Sold | $370,384 | $441,938 | $380,069 | $544,903 | $872,400 |
| Gross Profit | $809,305 | $764,280 | $691,901 | $1.1M | $1.4M |
| Operating Income | -$8.3M | -$11.6M | -$14.5M | -$17.8M | -$17.6M |
| Pre-Tax Income | -$7.5M | -$11.4M | -$14.2M | -$18.8M | -$18.6M |
| Income Tax | $4,000 | $6,300 | $4,338 | $9,602 | $1,297 |
| Net Income | -$7.5M | -$11.4M | -$14.2M | -$18.8M | -$18.6M |
| Diluted EPS | -$22.40 | -$19.20 | -$18.60 | -$17.00 | -$9.40 |
Femasys Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $729,394 | $813,387 | $424,889 | $331,827 |
| Net Income | -$4.2M | -$4.0M | $846,100 | -$4.5M |
| Diluted EPS | -$2.00 | -$0.10 | — | -$1.33 |
Femasys Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $24.8M | $13.0M | $21.7M | $3.5M | $9.3M |
| Current Assets | $25.6M | $14.1M | $23.2M | $8.0M | $16.5M |
| Total Assets | $28.6M | $16.9M | $27.8M | $12.4M | $20.7M |
| Current Liabilities | $1.7M | $1.5M | $3.1M | $8.6M | $3.6M |
| Total Long-Term Debt | — | — | $4.3M | — | $3.2M |
| Total Liabilities | $2.2M | $1.7M | $9.4M | $10.1M | $14.9M |
| Shareholders' Equity | $26.3M | $15.2M | $18.4M | $2.3M | $5.9M |
Femasys Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$7.9M | -$10.7M | -$11.3M | -$19.4M | -$18.7M |
| Cash From Investing | -$306,868 | -$407,475 | -$143,917 | -$847,764 | -$630,098 |
| Cash From Financing | $29.7M | -$681,645 | $20.2M | $2.0M | $25.1M |
| Free Cash Flow | -$8.2M | -$11.1M | -$11.4M | -$20.2M | -$19.2M |
Figures from Femasys' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Femasys financials page for every line item.
Femasys Company Profile
| Ticker | FEMY |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Suwanee, Georgia |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001339005 |
Frequently Asked Questions
What was Femasys' revenue in fiscal 2025?
Femasys (FEMY) reported revenue of $2.3M for fiscal 2025.
What is Femasys' annual revenue history?
Femasys' annual revenue by fiscal year: 2021: $1.2M; 2022: $1.2M; 2023: $1.1M; 2024: $1.6M; 2025: $2.3M.
What was Femasys' net income in fiscal 2025?
Femasys reported net income of -$18.6M for fiscal 2025.
What was Femasys' earnings per share (EPS) in fiscal 2025?
Femasys' diluted EPS was -$9.40 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Femasys generate in fiscal 2025?
Femasys generated -$19.2M of free cash flow in fiscal 2025.
What was Femasys' revenue last quarter?
In its most recent reported quarter (2026 Q2), Femasys reported revenue of $331,827.
How much debt does Femasys have?
Femasys reported $3.2M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Femasys are outstanding?
Femasys reported a weighted average of 3.4 million basic shares outstanding in 2026 Q2.
What is Femasys' market cap?
Based on its latest closing price, Femasys (FEMY) has a market capitalization of about $5.9M.
When does Femasys' fiscal year end?
Femasys' fiscal year end, as registered with the SEC, is December 31.
Where is Femasys headquartered?
Femasys lists its business address in Suwanee, Georgia in its SEC filings.
Femasys Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →